Collaboration, cost-cutting take hold at European chemical and drug companies

Article Abstract:

European pharmaceutical and chemical companies are reducing their R&D budgets despite an increase in their profits. These companies have turned their focus on speedier and less expensive product development through industry-wide collaborative laboratory research. Pharmaceutical companies are concentrating on the development of innovative medicines, which are less prone to price pressures, while German chemical companies are transferring R&D operations abroad to counter the effects of the strong German mark. Biotechnology is a promising area for the chemical and pharmaceutical industries, but is being hindered by poorly harmonized biotechnology patent rulesin the EC.

Pharmaceutical Preparation Manufacturing, Chemicals & Allied Products, Chemical Manufacturing, Pharmaceutical Preparations, Research, Pharmaceutical industry, Drugs, Chemicals, European Union, Chemical industry

---

U.S. companies are spending more on R&D, NSF finds

Article Abstract:

Several reports highlighted the increase in spending for research and development (R&D) in the US and other countries. The National Science Foundation (NSF) estimated R&D spending by US companies of $142 billion in 1996, $8 billion more than the preliminary estimate. NSF also forecasted increases in 1997 and 1998. The Dept of Commerce also noted a significant shift in R&D investments by industries, particularly in two sectors. As for other countries, the Organization for Economic Cooperation and Development reported growth of R&D spending in Japan and North America.

Commercial physical research

---

Silicon Fen boasts 1,200 tech companies

Article Abstract:

Silicon Fen in Cambridge, England, has managed to attract over 1,200 high-technology firms from the UK and overseas as of 1999. Europe's biggest and most prestigious park, which employs over 35,000 individuals, made a significant gain from only 400 startup companies registered in 1996. Silicon Fen's performance, which is expected to continue with the availability of venture capital, has been credited to the support given by Cambridge University.

High technology industry, Buildings and facilities, Location, England, Cambridge, England, Research parks

Similar abstracts:

• Abstracts: Transportation. Reversing sagging precollege skills in mathematics and science
• Abstracts: Revolutionary Law. Eden Valley holiday village enrages green campaigners. A capital case of political pride: following the launch of the 'London Pride Prospectus', success in achieving its goals will depend on winning the support of environmental secretary John Gummer
• Abstracts: Complementary questions about out-of-town proposals. Prematurity and call-ins dog retail proposals. Belts and braces
• Abstracts: Solid state. Educating the renaissance engineer. The uphill struggle: no rose garden for women in engineering
• Abstracts: Y2K testing: does success matter? Partners in platform design. An overview of high performance

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.